Novartis H5N1 pre-pandemic influenza vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novartis H5N1 pre-pandemic influenza vaccine, covering 2012-02-16 to 2012-02-16. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years [Phase 2]